TerrAscend Stock (CSE: TER) (OTCQX: TRSSF) - Investor Dashboard

Follow Company

➔ TerrAscend
CSE Ticker:	TER
OTCQX Ticker:	TRSSF

Market Focus:	Global
Classification:	Vertical Integration
Country:	Canada

Employees:	500+ as of 11/2019
Established:	2014
CEO:	Dr. Michael Nashat

Summary

Fiscal Year-End:	December
Facilities:	2
Dried Flower:	Production and Sale
Extracts:	Production and Sale
Number of Patients:	N/A
Headquarters:	Mississauga, ON

Financials (09/30/19)

Cash on hand:	$6.9 million
Fixed Investment:	$98.2million
Shareholders’ Equity:	$198.0 million
Revenues – Last Quarter:	$26.8 million
Adj. Gross Margin :	17.9%
EPS :	-0.33

Capital Structure (01/13/20)

Last Financing:	C$33.5 million units at C$2.45
Basic Shares:	181.5 million
Warrants:	23.1 million
Options:	10.9 million
Diluted Shares:	220.9 million

Company Brief

TerrAscend provides quality products, brands, and services to the global cannabinoid market.

As the first North American Operator (NAO), with scale operations in both Canada and the US, the Company participates in the medical and legal adult use market across Canada and in several US states where cannabis has been legalized for therapeutic or adult use.

Additionally, TerrAscend is the first and only cannabis company with sales in Europe as well as the US and Canada as it has received EU GMP certification for its manufacturing facility in Mississauga, Ontario.

A Strong Growth Platform

April 25, 2019 Investor Day Webcast

TerrAscend operates a number of synergistic businesses, including The Apothecarium, an award-winning cannabis dispensary with several retail locations in California and Nevada, such as: Ilera Healthcare, Pennsylvania’s premier medical marijuana cultivator, processor and dispenser; Arise Bioscience Inc., a manufacturer and distributor of hemp-derived products; Ascendant Laboratories Inc., a biotechnology and licensing company committed to the continuous improvement of cannabinoid expressing plants; and Solace RX Inc., a proposed Drug Preparation Premises (DPP) focused on the development of novel formulations and delivery forms. Additionally, TerrAscend has been chosen by the state of New Jersey to be one of six permit applicants for a vertically integrated medical cannabis operation.

Highlights

Canadian LP with global distribution; multi-state operator in the U.S.; nationwide distributor of hemp-derived CBD products; and drug development and R&D platform
Strategic investors include Canopy Growth, Canopy Rivers, and JW Funds
Management comprised of leaders from healthcare, pharmaceutical, banking, cannabis and online grocery industries
Strong pharmaceutical and distribution expertise
Unique ability to sell THC and CBD products within Canada, the U.S., and the European Union through TerrAscend’s manufacturing footprint
Brand portfolio including premium cannabis Haven St., Valhalla Confections, Funky Farms CBD extracts, Original Hemp, Knüba Naturals, State Flower, and Ilera

Growth Strategy

Focus on developing protectable intellectual property assets
Creating quality brands that resonate with patients and consumers
Multi-state operator (MSO) in the U.S. strongly positioned in the markets where it competes
Actively consolidating in the fragmented U.S. market
Canadian LP concentrating on production and manufacturing of cannabinoid products for medical and adult use consumers
Global export from EU GMP certified indoor cannabis facility in Mississauga, Ontario, Canada
U.S. nationwide distribution of hemp-derived CBD products through Arise Bioscience
R&D strategy supported by Ascendant Laboratories and Solace RX

Differentiators

First operator with scaled operations in both the U.S. and Canada, and first and only cannabis company with sales in the U.S., Canada and Europe
In the U.S., executing a focused MSO strategy with strong assets and competitive positioning in the markets it serves
One of six entities granted a permit to apply for a vertically integrated license in New Jersey, with TerrAscend located in the attractive North region
Significant market share in Pennsylvania’s limited license market via Ilera Healthcare, one of five super license holders in the state
Experienced leadership team with deep ties to global pharmaceutical distribution
Developing drug preparation premises (DPP) facility for non-cannabinoid formulations
Leverage proximity to Toronto to distribute on behalf of third-party LPs, with same-day delivery capabilities
Wholesale supply agreements with seven Canadian provinces
Proven consolidator with M&A expertise in the highly fragmented U.S. cannabis industry

The Four Pillars of TerrAscend

TerrAscend operates complementary business units that leverage its location, personnel, and strategic vision, providing a uniquely holistic business offering. TerrAscend believes that the cannabis space is much broader that just cultivating the crop, and as such, the company is working with strategic partners to develop businesses that complement the cannabis plant.

Advancing Research

Emphasis on developing protectible intellectual property
Advancing plant genetics and product formulations
Pharma-grade manufacturing facility

Building Brands

Developing trusted and recognized brands
Addressing needs of multiple cannabis business streams
Defining brands based on deep consumer insights

Promoting Responsibility

Ensuring highest standard of ethics and corporate integrity
Advocating responsible use of products
Exceeding industry and regulatory standards

Optimizing Wellness

Providing support for medical cannabis use
Guiding cannabis selection and consumption preferences
Enhancing the therapeutic application of cannabinoids

Institutional Analyst Coverage

Robert Fagan
GMP Securities

Noel Atkinson
Clarus Securities

Curated Stories & News

Visit TerrAscend, Inc.
at www.terrascend.com.